Cover Image
市場調查報告書

骨再生術:開發中產品分析

Bone Regeneration - Pipeline Review, H2 2014

出版商 Global Markets Direct 商品編碼 288831
出版日期 內容資訊 英文 35 Pages
訂單完成後即時交付
價格
Back to Top
骨再生術:開發中產品分析 Bone Regeneration - Pipeline Review, H2 2014
出版日期: 2014年09月15日 內容資訊: 英文 35 Pages
簡介

骨再生術是為了優化修復骨骼或回復骨骼機能,包含具有限制、暫時性、空間性序列的許多細胞種類及細胞內、細胞外分子信號途徑,刺激骨生長的複雜生物學性現象。骨再生術是在外傷、感染症、腫瘍切除及骨骼異常等造成大規模骨骼缺損的情況下,再生過程不可或缺的。

本報告提供骨再生術的治療藥開發情形調查分析,提供開發中產品的概要,臨床實驗各階段的產品概要,再加上主要企業簡介,藥物簡介,開發中產品趨勢等相關資料,有系統的資訊。

目錄

簡介

骨再生術概要

治療藥的開發

  • 開發中產品:概要
  • 開發中產品:比較分析

正在開發的治療藥:各企業

調查中的產品:大學/研究機關別

開發中產品的概要

  • 初期階段的產品

開發中的產品:各企業

調查中的產品:大學/研究機關別

治療藥的的開發企業

  • CYATHUS EXQUIRERE PharmaforschungsGmbH
  • GliaMed, Inc.
  • Histocell S.L.
  • Bioventus LLC
  • Samumed

治療藥的評估

  • 單獨療法的情況
  • 標的別
  • 各作用機制
  • 各給藥途徑
  • 各類型分子

藥物簡介

  • WX-04554
  • HR-004
  • Small Molecule to Activate Integrin Alpha 5 for Bone Repair And Regeneration
  • Chordin
  • Cyathus-1103-B
  • GM-1485
  • Fibroblast Growth Factor Conjugate
  • Protein Fractions
  • 整形外科治療用的重組蛋白

暫停的計劃

附錄

圖表

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: GMDHC5503IDB

Summary

Global Markets Direct's, 'Bone Regeneration - Pipeline Review, H2 2014', provides an overview of the Bone Regeneration's therapeutic pipeline.

This report provides comprehensive information on the therapeutic development for Bone Regeneration, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Bone Regeneration and special features on late-stage and discontinued projects.

Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • The report provides a snapshot of the global therapeutic landscape of Bone Regeneration
  • The report reviews key pipeline products under drug profile section which includes, product description, MoA and R&D brief, licensing and collaboration details & other developmental activities
  • The report reviews key players involved in the therapeutics development for Bone Regeneration and enlists all their major and minor projects
  • The report summarizes all the dormant and discontinued pipeline projects
  • A review of the Bone Regeneration products under development by companies and universities/research institutes based on information derived from company and industry-specific sources
  • Pipeline products coverage based on various stages of development ranging from pre-registration till discovery and undisclosed stages
  • A detailed assessment of monotherapy and combination therapy pipeline projects
  • Coverage of the Bone Regeneration pipeline on the basis of target, MoA, route of administration and molecule type
  • Latest news and deals relating related to pipeline products

Reasons to buy

  • Provides strategically significant competitor information, analysis, and insights to formulate effective R&D development strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Develop strategic initiatives by understanding the focus areas of leading companies
  • Identify and understand important and diverse types of therapeutics under development for Bone Regeneration
  • Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
  • Devise corrective measures for pipeline projects by understanding Bone Regeneration pipeline depth and focus of Indication therapeutics
  • Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
  • Modify the therapeutic portfolio by identifying discontinued projects and understanding the factors that drove them from pipeline

Table of Contents

  • Table of Contents
    • List of Tables
    • List of Figures
  • Introduction
    • Global Markets Direct Report Coverage
  • Bone Regeneration Overview
  • Therapeutics Development
    • Pipeline Products for Bone Regeneration - Overview
    • Pipeline Products for Bone Regeneration - Comparative Analysis
  • Bone Regeneration - Therapeutics under Development by Companies
  • Bone Regeneration - Therapeutics under Investigation by Universities/Institutes
  • Bone Regeneration - Pipeline Products Glance
    • Early Stage Products
  • Bone Regeneration - Products under Development by Companies
  • Bone Regeneration - Products under Investigation by Universities/Institutes
  • Bone Regeneration - Companies Involved in Therapeutics Development
    • CYATHUS EXQUIRERE PharmaforschungsGmbH
    • Histocell S.L.
  • Bone Regeneration - Therapeutics Assessment
    • Assessment by Monotherapy Products
    • Assessment by Target
    • Assessment by Mechanism of Action
    • Assessment by Molecule Type
  • Drug Profiles
    • WX-04554 - Drug Profile
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • HR-004 - Drug Profile
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • Drugs to Activate Integrin Alpha 5 for Bone Repair and Bone Regeneration - Drug Profile
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • Chordin - Drug Profile
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • Cyathus-1103-B - Drug Profile
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • Recombinant Erythropoetin For Wounds and Bone Regeneration - Drug Profile
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • HC-016 - Drug Profile
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • LWnt-3a - Drug Profile
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • Protein to Activate FGFR for Dermatology, CNS, Cardiovascular and Musculoskeletal Disorders - Drug Profile
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • Proteins for CNS, Cardiovascular and Musculoskeletal Disorders - Drug Profile
      • Product Description
      • Mechanism of Action
      • R&D Progress
  • Bone Regeneration - Dormant Projects
  • Appendix
    • Methodology
    • Coverage
    • Secondary Research
    • Primary Research
    • Expert Panel Validation
    • Contact Us
    • Disclaimer

List of Tables

  • Number of Products under Development for Bone Regeneration, H2 2014
  • Number of Products under Development for Bone Regeneration - Comparative Analysis, H2 2014
  • Number of Products under Development by Companies, H2 2014
  • Number of Products under Investigation by Universities/Institutes, H2 2014
  • Comparative Analysis by Early Stage Development, H2 2014
  • Products under Development by Companies, H2 2014
  • Products under Investigation by Universities/Institutes, H2 2014
  • Bone Regeneration - Pipeline by CYATHUS EXQUIRERE PharmaforschungsGmbH, H2 2014
  • Bone Regeneration - Pipeline by Histocell S.L., H2 2014
  • Assessment by Monotherapy Products, H2 2014
  • Number of Products by Stage and Target, H2 2014
  • Number of Products by Stage and Mechanism of Action, H2 2014
  • Number of Products by Stage and Molecule Type, H2 2014
  • Bone Regeneration - Dormant Projects, H2 2014

List of Figures

  • Number of Products under Development for Bone Regeneration, H2 2014
  • Number of Products under Development for Bone Regeneration - Comparative Analysis, H2 2014
  • Number of Products under Investigation by Universities/Institutes, H2 2014
  • Comparative Analysis by Early Stage Products, H2 2014
  • Assessment by Monotherapy Products, H2 2014
  • Number of Products by Top 10 Target, H2 2014
  • Number of Products by Stage and Top 10 Target, H2 2014
  • Number of Products by Top 10 Mechanism of Action, H2 2014
  • Number of Products by Stage and Top 10 Mechanism of Action, H2 2014
  • Number of Products by Top 10 Molecule Type, H2 2014
  • Number of Products by Stage and Top 10 Molecule Type, H2 2014
Back to Top